PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Schirmer, D.* ; Storz, I.* ; Wisskirchen, K. ; Feederle, R. ; Schmidt, O.* ; Abken, H.* ; Protzer, U.* ; Burdach, S.* ; Richter, G.*

GPR64-specific CAR-trnasgenic T cells selectively kill Ewing sarcoma cells.

Oncol. Res. Treat. 41, 130-130 (2018)
Open Access Green as soon as Postprint is submitted to ZB.
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Meeting abstract
Language english
Publication Year 2018
HGF-reported in Year 2018
ISSN (print) / ISBN 2296-5270
e-ISSN 2296-5262
Journal Oncology Research and Treatment
Quellenangaben Volume: 41, Issue: , Pages: 130-130 Article Number: , Supplement: ,
Publisher Karger
Publishing Place Basel
Reviewing status Peer reviewed
Institute(s) Institute of Virology (VIRO)
CF Monoclonal Antibodies (CF-MAB)
POF-Topic(s) 30203 - Molecular Targets and Therapies
30201 - Metabolic Health
Research field(s) Immune Response and Infection
Helmholtz Diabetes Center
PSP Element(s) G-502700-003
G-502210-001
WOS ID WOS:000424914300351
Erfassungsdatum 2018-03-10
[➜Report correction]